Home » Topics » BioWorld Science

BioWorld Science
RSS

Univ. of Washington offers human topo I-producing system for licensing

Nov. 29, 1996

New serotoninergic drugs from E. Merck

Nov. 29, 1996

Novel nonmacrolide antitumor agent discovered by Mitsubishi

Nov. 29, 1996

Takeda discloses natural ET receptor antagonist

Nov. 29, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

New bombesin analogues from Biomeasure

Nov. 29, 1996

Merck & Co. describes new compounds for dopamine-related disorders

Nov. 29, 1996

New market introduction for antiestrogen

Nov. 28, 1996

Another European market introduction for Epivir

Nov. 28, 1996

New 5-FU formulation reduces toxicity in mice

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.